Mary Agnes Wilderotter Sells 1,096 Shares of Docusign (NASDAQ:DOCU) Stock

Docusign Inc. (NASDAQ:DOCU) Director Mary Wilderotter sold 1,096 shares of the business’s stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $70.60, for a total transaction of $77,377.60. Following the transaction, the director directly owned 3,199 shares in the company, valued at $225,849.40. The trade was a 25.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Stock Performance

Docusign stock opened at $70.64 on Friday. Docusign Inc. has a twelve month low of $40.16 and a twelve month high of $86.65. The firm has a market cap of $13.20 billion, a PE ratio of 43.07, a P/E/G ratio of 2.65 and a beta of 0.90. The firm’s 50 day moving average price is $59.60 and its two-hundred day moving average price is $51.41.

Docusign (NASDAQ:DOCU) last issued its earnings results on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.09 by $0.07. Docusign had a net margin of 9.82% and a return on equity of 18.29%. The company had revenue of $875.75 million during the quarter, compared to analyst estimates of $867.22 million. During the same quarter last year, the business posted $0.30 EPS. The company’s revenue for the quarter was up 9.4% on a year-over-year basis. Equities analysts anticipate that Docusign Inc. will post 2.1 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

DOCU has been the topic of several research reports. Evercore set a $65.00 target price on Docusign in a research report on Friday, September 4th. Piper Sandler lifted their price target on Docusign from $52.00 to $75.00 and gave the company a “neutral” rating in a report on Friday, September 4th. UBS Group boosted their price target on Docusign from $54.00 to $70.00 and gave the company a “neutral” rating in a research note on Friday, September 4th. Jefferies Financial Group increased their price objective on Docusign from $45.00 to $50.00 and gave the stock a “hold” rating in a report on Friday, June 5th. Finally, Citizens Jmp reaffirmed a “market outperform” rating and set a $86.00 price objective on shares of Docusign in a research report on Friday, September 4th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Docusign presently has a consensus rating of “Hold” and a consensus price target of $67.33.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Customer expansion, increasing IAM adoption and stronger cash flow are supporting the recent rally. Investors view IAM as a potential driver of higher-value software sales and broader customer engagement. Can DOCU Extend Its 13.4% Gain as IAM Momentum Builds?
• Positive Sentiment: Docusign’s latest quarterly results exceeded expectations, with revenue of $875.75 million, adjusted EPS of $1.16 versus a $1.09 consensus estimate, and 9.4% year-over-year revenue growth. The improved earnings outlook is reinforcing the bullish case. Docusign Stock and IAM Growth
• Positive Sentiment: Analysts have raised price targets as Docusign’s AI and IAM strategy gains attention, while the company’s large share-repurchase program may support EPS and shareholder returns. These factors are helping sustain investor interest after the recent advance.
• Neutral Sentiment: Director Mary Agnes Wilderotter sold 1,096 shares for approximately $77,378, and Director Anna Marrs sold 548 shares for about $36,716. Both transactions were made under pre-arranged Rule 10b5-1 plans, reducing their significance as indicators of management sentiment. SEC Insider Trading Filing
• Negative Sentiment: Liquidity concerns, pricing pressure and the need to convert IAM adoption into sustained revenue growth remain risks. Docusign also trades at roughly 43 times earnings, while the overall analyst consensus remains “Hold,” potentially limiting near-term upside after the rally. Is Docusign Stock Worth Buying as IAM Growth Meets Liquidity Risks?

Hedge Funds Weigh In On Docusign

Several institutional investors have recently bought and sold shares of the stock. Tred Avon Family Wealth LLC raised its stake in shares of Docusign by 3.6% during the first quarter. Tred Avon Family Wealth LLC now owns 6,176 shares of the company’s stock valued at $293,000 after acquiring an additional 215 shares during the last quarter. First Citizens Bank & Trust Co. grew its stake in shares of Docusign by 2.1% in the first quarter. First Citizens Bank & Trust Co. now owns 11,745 shares of the company’s stock worth $557,000 after purchasing an additional 239 shares during the last quarter. PNC Financial Services Group Inc. grew its stake in shares of Docusign by 4.1% in the fourth quarter. PNC Financial Services Group Inc. now owns 6,789 shares of the company’s stock worth $464,000 after purchasing an additional 267 shares during the last quarter. Integrated Wealth Concepts LLC increased its holdings in Docusign by 2.0% in the second quarter. Integrated Wealth Concepts LLC now owns 14,359 shares of the company’s stock valued at $638,000 after purchasing an additional 277 shares during the period. Finally, Harbour Investments Inc. increased its holdings in Docusign by 56.6% in the fourth quarter. Harbour Investments Inc. now owns 797 shares of the company’s stock valued at $55,000 after purchasing an additional 288 shares during the period. 77.64% of the stock is currently owned by institutional investors.

About Docusign

DocuSign, Inc is a provider of digital agreement management and electronic signature solutions. Its platform enables individuals and organizations to prepare, send, sign, manage and store agreements electronically, helping businesses replace paper-based contracting processes with digital workflows.

The company’s products and services include DocuSign eSignature, which supports electronic signing and authentication, as well as tools for contract lifecycle management, agreement preparation, identity verification, notarial services and workflow automation.